OrthoPediatrics Q3 2026 net loss narrows 50% to $5.93 million
KIDS•OrthoPediatrics’ third-quarter 2026 net loss narrowed 50% year over year to $5.93 million, while revenue rose 19% to $72.7 million. The company raised its full-year revenue guidance to $270 million–$273 million, representing 14%–16% growth over 2025.
1. Quarterly results
OrthoPediatrics’ third-quarter 2026 net loss narrowed 50% year over year to $5.93 million. Revenue rose 19% to $72.7 million, driven primarily by global Trauma and Deformity and OPSB products.
2. Products and guidance
The company released the 3P Pediatric Plating Platform Hip System and PediHip Rigid Brace for the full market. It raised full-year 2026 revenue guidance to $270 million–$273 million, representing growth of 14%–16% over 2025.
